Clinical Trial Update: Noradrenergic Add-on Therapy With Guanfacine [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 clinical trial evaluating guanfacine as an add-on therapy for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Imperial College London | Conditions: Alzheimer Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING